Clinical Trials Browser

OTHER × Post-Acute COVID-19 Syndrome × Ipilimumab × Clear all

NCT05597800 2022-10-28

LUNGVIR

Phase 2 Not yet recruiting

Post-Acute COVID-19 Syndrome, Carcinoma, Non-Small-Cell Lung